Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001188112-14-000728
Filing Date
2014-03-19
Accepted
2014-03-19 16:39:06
Documents
5
Group Members
DANIEL J. DONOGHUEDISCOVERY EQUITY PARTNERS, L.P.MICHAEL R. MURPHY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 8) t78676_sc13da.htm SC 13D/A 124641
2 EXHIBIT 1 ex1.htm EX-1 90097
3 EXHIBIT 2 ex2.htm EX-2 12176
4 EXHIBIT 3 ex3.htm EX-3 11467
5 EXHIBIT 4 ex4.htm EX-4 11172
  Complete submission text file 0001188112-14-000728.txt   251161
Mailing Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606
Business Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606 (312) 265-96000
Discovery Group I, LLC (Filed by) CIK: 0001312548 (see all company filings)

IRS No.: 300075077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 520 LAKE COOK ROAD SUITE 520 DEERFIELD IL 60062
Business Address 520 LAKE COOK ROAD SUITE 520 DEERFIELD IL 60062 224-383-3000
HORIZON PHARMA, INC. (Subject) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86365 | Film No.: 14704375
SIC: 2834 Pharmaceutical Preparations